TipRanks
Go Ultimate55% OFF

Moleculin Biotech (MOL) Income Statement

Moleculin Biotech Income Statement

Last quarter (Q2 2026), Moleculin Biotech's total revenue was $0.00. In Q2, Moleculin Biotech's net income was $-7.63M. See Moleculin Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -90.00K$ 0.00$ 0.00$ 0.00$ 0.00
$ 25.10M$ 26.64M$ 29.63M$ 30.64M$ 22.97M
Depreciation and Amortization$ 90.00K$ 126.00K$ 127.00K$ 130.00K$ 164.00K
$ -33.47M$ -21.64M$ -29.64M$ -28.89M$ -15.73M
$ -25.10M$ -26.64M$ -29.63M$ -30.64M$ -22.97M
$ -8.46M$ 4.88M$ -138.00K$ 1.61M$ 7.07M
$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
Per Share Metrics
Basic EPS$ -568.40$ -3782.80$ -7534.20$ -7610.20$ -4435.40
Diluted EPS$ -568.40$ -3782.80$ -7534.20$ -7610.20$ -4435.40
Weighted Average Shares Outstanding59.23K6.89K3.95K3.81K3.58K
Weighted Average Shares Outstanding (Diluted)59.23K6.89K3.95K3.81K3.58K

Currency in USD

Moleculin Biotech Earnings and Revenue History

-36M-24M-12M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin